The year in cardiovascular medicine 2023: the top 10 papers in thrombosis and antithrombotic treatment

Felicita Andreotti; Michelle L. O'Donoghue; Jurrien M. Ten Berg

doi:10.1093/eurheartj/ehae123

The year in cardiovascular medicine 2023: the top 10 papers in thrombosis and antithrombotic treatment

Felicita Andreotti^*, Michelle L. O'Donoghue, Jurrien M. Ten Berg

^*Corresponding author for this work

Research output: Contribution to journal › Editorial › Academic › peer-review

Abstract

Main findings of recent pivotal papers on antithrombotic strategies. Favourable, uncertain, or mostly harmful results summarized in 10 boxes distributed from left to right. a, activated; CHADSVA, Congestive heart failure, Hypertension, Age, Diabetes, Stroke, and VAscular disease thrombotic risk score; DAPT, dual antiplatelet therapy; F, factor; IV, intravenous; PCI, percutaneous coronary intervention; TAVI, transcatheter aortic valve implantation; UFH, unfractionated heparin

Original language	English
Pages (from-to)	1727-1729
Number of pages	3
Journal	European Heart Journal
Volume	45
Issue number	19
Early online date	1 Mar 2024
DOIs	https://doi.org/10.1093/eurheartj/ehae123
Publication status	Published - 14 May 2024

Keywords

BIVALIRUDIN
HEPARIN

Access to Document

10.1093/eurheartj/ehae123Licence: Other

Cite this

@article{28caa728e5fd4a5caca6d302edaa39c3,

title = "The year in cardiovascular medicine 2023: the top 10 papers in thrombosis and antithrombotic treatment",

abstract = "Main findings of recent pivotal papers on antithrombotic strategies. Favourable, uncertain, or mostly harmful results summarized in 10 boxes distributed from left to right. a, activated; CHADSVA, Congestive heart failure, Hypertension, Age, Diabetes, Stroke, and VAscular disease thrombotic risk score; DAPT, dual antiplatelet therapy; F, factor; IV, intravenous; PCI, percutaneous coronary intervention; TAVI, transcatheter aortic valve implantation; UFH, unfractionated heparin",

keywords = "BIVALIRUDIN, HEPARIN",

author = "Felicita Andreotti and O'Donoghue, {Michelle L.} and {Ten Berg}, {Jurrien M.}",

year = "2024",

month = may,

day = "14",

doi = "10.1093/eurheartj/ehae123",

language = "English",

volume = "45",

pages = "1727--1729",

journal = "European Heart Journal",

issn = "0195-668X",

publisher = "Oxford University Press",

number = "19",

}

TY - JOUR

T1 - The year in cardiovascular medicine 2023

T2 - the top 10 papers in thrombosis and antithrombotic treatment

AU - Andreotti, Felicita

AU - O'Donoghue, Michelle L.

AU - Ten Berg, Jurrien M.

PY - 2024/5/14

Y1 - 2024/5/14

N2 - Main findings of recent pivotal papers on antithrombotic strategies. Favourable, uncertain, or mostly harmful results summarized in 10 boxes distributed from left to right. a, activated; CHADSVA, Congestive heart failure, Hypertension, Age, Diabetes, Stroke, and VAscular disease thrombotic risk score; DAPT, dual antiplatelet therapy; F, factor; IV, intravenous; PCI, percutaneous coronary intervention; TAVI, transcatheter aortic valve implantation; UFH, unfractionated heparin

AB - Main findings of recent pivotal papers on antithrombotic strategies. Favourable, uncertain, or mostly harmful results summarized in 10 boxes distributed from left to right. a, activated; CHADSVA, Congestive heart failure, Hypertension, Age, Diabetes, Stroke, and VAscular disease thrombotic risk score; DAPT, dual antiplatelet therapy; F, factor; IV, intravenous; PCI, percutaneous coronary intervention; TAVI, transcatheter aortic valve implantation; UFH, unfractionated heparin

KW - BIVALIRUDIN

KW - HEPARIN

U2 - 10.1093/eurheartj/ehae123

DO - 10.1093/eurheartj/ehae123

M3 - Editorial

SN - 0195-668X

VL - 45

SP - 1727

EP - 1729

JO - European Heart Journal

JF - European Heart Journal

IS - 19

ER -

The year in cardiovascular medicine 2023: the top 10 papers in thrombosis and antithrombotic treatment

Abstract

Keywords

Access to Document

Fingerprint

Cite this